Errikos Petsas

7PUBLICATIONS
9CO-AUTHORS
Metabolic medicineMolecular medicineMolecular targetsCheminformatics and quantitative structure-activity relationships
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jun 26, 2026
Targeting the Crosstalk Between Metabolism and Chronic Inflammation: In Silico Multitargeting Drug Design Approach for Cardiometabolic Syndrome.

|Feb 27, 2026
Correction: Petsas et al. Protein-Ligand Interactions in Cardiometabolic Drug Targets: Focus on Weight Loss and Cardioprotection. Molecules 2025, 30, 4240.

Errikos Petsas, Despoina P Kiouri, Nikitas Georgiou

|Jan 28, 2026
Recent Advances in Dual COX/LOX Inhibitor Design (2020-2024): Establishing "The Rule of Four for Inflammation".

Filippos Panteleimon Chatzipieris, Errikos Petsas, George Lambrinidis

|Jan 28, 2026
Structural and Computational Insights into the Angiotensin II Type 1 Receptor: Advances in Antagonist Design and Implications for Hypertension Therapy (2020-2024).

Filippos Panteleimon Chatzipieris, Errikos Petsas, George Lambrinidis

|Dec 11, 2025
Structure-Based Design and In Silico Evaluation of a Lipophilic Cyclooctanoyl- Derivative as a Renin Inhibitor: Lessons from Withdrawn Aliskiren.

Dimitrios Pavlos, Errikos Petsas, Filippos Panteleimon Chatzipieris

|Nov 13, 2025
Protein-Ligand Interactions in Cardiometabolic Drug Targets: Focus on Weight Loss and Cardioprotection.

Errikos Petsas, Despoina P Kiouri, Nikitas Georgiou

Pageof 2

Frequent Collaborators

5 joint publications

Thomas Mavromoustakos

4 joint publications

Filippos Panteleimon Chatzipieris

3 joint publications

Nikitas Georgiou

3 joint publications

Christos T Chasapis